PAR AND SPECTRUM JOIN TO DISTRIBUTE GENERICS

Publication
Article
Pharmacy Times
Volume 0
0

Spectrum Pharmaceuticals will begindistribution of generic drugs produced byPar Pharmaceutical under a new strategicalliance agreed to by the 2 companies.Under the agreement, Par will makean unspecified equity investment inSpectrum, and Spectrum will receive paymentsbased on achievement of specifiedregulatory approvals that companyofficials believe to be worth over $10 million.Par will also provide financial andlegal support for the ongoing patentchallenge for sumatriptan injection—amigraine treatment originally developedby GlaxoSmithKline—and both companieswill share profits resulting from thesale of the generic products.

Related Videos
Practice Pearl #1 Active Surveillance vs Treatment in Patients with NETs
© 2024 MJH Life Sciences

All rights reserved.